Daniel G. Eramian

Overview

Daniel G. Eramian received an average of $1M in total compensation, including $308K in salary, at CTI BioPharma from 2007 to 2012.

Related executives

We found 14 more executives who work or worked at CTI BioPharma.

Adam Craig

CTI BioPharma

Chief Executive Officer

Bruce Seeley

CTI BioPharma

Chief Operating Officer

David Kirske

CTI BioPharma

Chief Financial Officer

Jack Singer

CTI BioPharma

Chief Scientific Officer

Louis Bianco

CTI BioPharma

Former Executive Vice President, Finance and Administration

Matthew Plunkett

CTI BioPharma

Former Executive Vice President, Chief Business Officer

Richard Love

CTI BioPharma

Chief Executive Officer

James Bianco

CTI BioPharma

Chief Executive Officer

You may also like